Preliminary report of tolvaptan treatment in Japanese patients with heart failure
Hiroaki Semba1, Koichiro Kinugawa, Norihiko Takeda
1Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
Abstract:
While diuretic drugs are commonly used in patients with congestive heart failure, the efficacy of their long-term use still remains controversial. Recently, a new class of diuretics, vasopressin receptor 2 antagonists, has been launched, and tolvaptan is one such drug. We describe our initial experience with this novel agent. Tolvaptan is potentially useful for treatment of heart failure patients with fluid overload who are refractory to conventional diuretic therapies.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Heart Failure V: Medical Management
